Xcel Brands, Inc. — FY 2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014; this is an annual filing, not a standalone fourth-quarter report. The filing compares FY 2014 with FY 2013 and was signed March 31, 2015.
Business context
Xcel manages consumer brands and earns most revenue from licensing royalties and design and service fees, while licensees generally handle manufacturing and distribution. Its portfolio included Isaac Mizrahi, Judith Ripka, H Halston and certain Liz Claiborne New York rights. Xcel acquired the Ripka brands in April 2014 and H Halston in December 2014. In December, it decided to close its retail stores; e-commerce continued within the licensing business.
Financial performance and liquidity
| Metric | FY 2014 | FY 2013 |
|---|---|---|
| Total revenue | $20.71 million | $13.17 million |
| Net licensing revenue | $19.13 million | $11.55 million |
| Design and service fee revenue | $1.46 million | $1.62 million |
| Net income (loss) from continuing operations | $0.04 million | $1.69 million |
| Net income (loss) | $(1.03) million | $1.53 million |
| Operating income | $1.44 million | $2.09 million |
| Adjusted EBITDA (non-GAAP) | $7.01 million | $4.15 million |
| Cash from operating activities | $5.87 million | $2.38 million |
| Cash and cash equivalents at year-end | $8.53 million | $7.46 million |
- Revenue rose about 57%, mainly from a $7.10 million increase in direct-response television royalties, including the newly acquired Ripka business and growth in Isaac Mizrahi licensing. Gross profit was $20.63 million versus $13.17 million; the gross margin was approximately 99.6% in 2014, reflecting the licensing-heavy model.
- Operating expenses increased to $19.80 million from $14.84 million, including higher compensation, design and marketing costs, and stock-based compensation. Interest and finance expense was $1.49 million, down from $1.73 million.
- The net loss primarily reflected $1.08 million of losses from discontinued retail operations, including store wind-down costs, inventory write-downs and asset impairment. Continuing-operations income was nearly break-even.
- Adjusted EBITDA is a company-defined non-GAAP measure; it excludes, among other items, stock-based compensation and discontinued-operations losses. It should not be treated as a substitute for GAAP earnings or cash flow.
- Net cash used in investing was $31.56 million, largely for the Ripka and H Halston acquisitions. Financing activities provided $26.76 million, including $19.00 million of term-loan proceeds and $9.29 million of net proceeds from a common-stock offering.
- At year-end, reported current assets were $13.84 million and current liabilities $17.61 million. Management cited a 1.47-to-1 working-capital ratio after excluding current contingent obligations and a specified Ripka seller-note payment; the basis differs from the unadjusted balance-sheet totals.
- Bank term loans totaled $31.75 million in principal at year-end. The balance sheet reported $51.06 million of total debt carrying value including seller notes and contingent obligations; it classified $11.42 million as current. These measures are not directly interchangeable.
Material changes and unusual items
- Ripka contributed to FY 2014 results after its April acquisition; H Halston was acquired in December and had not yet launched products. The H by Halston QVC launch was planned for fall 2015.
- QVC accounted for 72% of FY 2014 revenue, up from 62% in FY 2013. The Isaac Mizrahi QVC agreement alone represented 51% of 2014 revenue; Ripka QVC represented 22% for its partial-year period.
- Xcel recorded a $0.60 million gain from reducing an Isaac Mizrahi contingent obligation, based on revised royalty projections. The comparable prior-year gain was $5.12 million, alongside a $1.35 million debt-extinguishment loss from refinancing.
- Acquisition financing and consideration included new secured debt, seller notes, contingent obligations, common shares and warrants. In December 2014, Xcel also raised $9.78 million gross by issuing 1,086,667 shares at $9.00 per share.
- Subsequent events included a February 2015 amendment and settlement arrangement for part of the Ripka seller notes, a $0.9 million Ripka installment paid in February, and a further $1.3 million installment scheduled for April, subject to lender approval.
Outlook, risks and contingencies
- Management said existing cash and expected operating cash flow should cover operating needs, debt service and capital expenditures for at least 12 months after December 31, 2014. This depends on licensees performing as expected. Management also identified 2015 growth, international expansion and further brand development as priorities.
- Debt is secured by substantially all relevant brand assets and is subject to financial covenants, including minimum EBITDA, fixed-charge coverage, net-worth and liquidity requirements. The filing reported covenant compliance at December 31, 2014; future breaches could permit acceleration or foreclosure. QVC agreement termination could also trigger a credit-facility default.
- Revenue concentration with QVC, reliance on key brand personalities, licensee performance, changing consumer demand, competition, acquisition integration, foreign manufacturing and trademark protection are material risks.
- Potential earn-outs and seller obligations may be payable in cash or shares, depending on their terms and Xcel’s options. Share issuance, warrants, options and the expanded equity plan could materially dilute existing holders.
- The common stock was thinly traded on OTCQX; a NASDAQ listing application was filed in February 2015 in connection with a proposed equity offering. Xcel did not expect to pay dividends.
- Management concluded disclosure controls and internal control over financial reporting were effective as of year-end. The independent auditor issued an unqualified opinion on the financial statements but did not attest to internal-control effectiveness.
Investor verification priorities
- Reconcile the $51.06 million reported debt carrying value with scheduled bank debt, seller notes, contingent obligations and post-year-end payments or amendments.
- Review covenant headroom and required 2015 debt service, including lender approvals affecting cash payments and any excess-cash-flow sweeps.
- Assess QVC revenue concentration and the contractual restrictions, renewal terms and termination/default links across the QVC agreements.
- Validate the assumptions behind Adjusted EBITDA, contingent-obligation valuations and projected royalties, and compare these with GAAP earnings and operating cash flow.
- Estimate potential dilution from outstanding equity awards, warrants, acquisition consideration and earn-outs; verify subsequent share issuances and the NASDAQ/offering status.
- Monitor the retail-store wind-down, planned H Halston launches, and whether management’s liquidity outlook remains supported by actual licensing receipts.